| Product Code: ETC9520737 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname rapid acting insulin import market in 2024 saw major contributions from top exporting countries including the United States, Netherlands, Brazil, United Kingdom, and India. Despite a high concentration level indicated by the Herfindahl-Hirschman Index (HHI), the market experienced a significant decline with a Compound Annual Growth Rate (CAGR) of -26.83% from 2020 to 2024. The growth rate from 2023 to 2024 further decreased by -67.36%. These figures suggest a challenging market environment with potential shifts in supply dynamics and pricing strategies impacting the import landscape for rapid acting insulin in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Rapid Acting Insulin Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Rapid Acting Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Rapid Acting Insulin Market - Industry Life Cycle |
3.4 Suriname Rapid Acting Insulin Market - Porter's Five Forces |
3.5 Suriname Rapid Acting Insulin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Suriname Rapid Acting Insulin Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Suriname Rapid Acting Insulin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Rapid Acting Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname Rapid Acting Insulin Market Trends |
6 Suriname Rapid Acting Insulin Market, By Types |
6.1 Suriname Rapid Acting Insulin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Suriname Rapid Acting Insulin Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Suriname Rapid Acting Insulin Market Revenues & Volume, By Lispro Insulin, 2021- 2031F |
6.1.4 Suriname Rapid Acting Insulin Market Revenues & Volume, By Aspart Insulin, 2021- 2031F |
6.1.5 Suriname Rapid Acting Insulin Market Revenues & Volume, By Glulisine Insulin, 2021- 2031F |
6.2 Suriname Rapid Acting Insulin Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Suriname Rapid Acting Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021- 2031F |
6.2.3 Suriname Rapid Acting Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F |
6.3 Suriname Rapid Acting Insulin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Suriname Rapid Acting Insulin Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Suriname Rapid Acting Insulin Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.3.4 Suriname Rapid Acting Insulin Market Revenues & Volume, By Online Stores, 2021- 2031F |
7 Suriname Rapid Acting Insulin Market Import-Export Trade Statistics |
7.1 Suriname Rapid Acting Insulin Market Export to Major Countries |
7.2 Suriname Rapid Acting Insulin Market Imports from Major Countries |
8 Suriname Rapid Acting Insulin Market Key Performance Indicators |
9 Suriname Rapid Acting Insulin Market - Opportunity Assessment |
9.1 Suriname Rapid Acting Insulin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Suriname Rapid Acting Insulin Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Suriname Rapid Acting Insulin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Rapid Acting Insulin Market - Competitive Landscape |
10.1 Suriname Rapid Acting Insulin Market Revenue Share, By Companies, 2024 |
10.2 Suriname Rapid Acting Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |